Status:
COMPLETED
A Mixed Methods Study to Explore the Feasibility of a Novel Continuous Fetal Monitoring Device
Lead Sponsor:
University of Manchester
Conditions:
Fetal Distress
Fetal Heart Rate Disorder Nos
Eligibility:
FEMALE
18-50 years
Brief Summary
A stillbirth describes when a baby dies after 24 weeks of pregnancy and before being born. In the UK there are roughly 9 stillbirths every day. Normally, before a stillbirth occurs changes such as a s...
Detailed Description
In the United Kingdom (UK) stillbirth is defined as the death of a fetus before birth and after 24 weeks gestation. The incidence of stillbirth in the UK was 4.6 per 1000 in 2014. The annual rate of r...
Eligibility Criteria
Inclusion
- Women with singleton pregnancies attending St. Mary's Hospital, Manchester for antenatal care
- No abnormality identified on ultrasound scan of fetal biometry and umbilical and fetal Doppler indices
- Gestational age \>24 weeks
- Able to give informed consent
Exclusion
- Multiple pregnancies
- Maternal age \<18 years
- Individuals who do cannot speak or do not understand fluent English
- Individuals unable to give informed consent
- Women in active labour
Key Trial Info
Start Date :
June 22 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03370822
Start Date
June 22 2016
End Date
December 31 2017
Last Update
May 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Manchester University Hospitals NHS Foundation Trust
Manchester, United Kingdom, M13 9WL